Clinical Trial Update: Phase 2 Randomized Study of PG-102 vs Placebo and Semaglutide in Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 randomized study comparing PG-102 against placebo and semaglutide in Type 2 Diabetes Mellitus, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PG-102 (PG-102)
• semaglutide (semaglutide)

Snippet

Sponsor: ProGen. Co., Ltd. | Conditions: Type 2 Diabetes Mellitus (T2DM) | Phase 2 | Status: NOT_YET_RECRUITING